Economy
1Β month, 4Β weeks ago
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.
Impact on BIOTECH COMPANY'S TICKER SYMBOL (NOT SPECIFIED IN THE ARTICLE):
The $181 million investment and 1,300% stock rally may lead to increased β¦
A clinical-stage biotech company has attracted a $181 million investment, coinciding with a staggering 1,300% β¦
High (80%)
View full analysis β